Do White People Get Eczema? Rates and Symptoms

Yes, white people get eczema. In fact, about 7.7% of non-Hispanic white adults in the United States have been diagnosed with the condition, making it one of the most common skin problems in this population. That rate is close to the national average of 7.3% across all adults.

How Common Is Eczema Across Racial Groups

Eczema affects every racial and ethnic group, though rates vary somewhat. CDC data from 2021 shows non-Hispanic Black adults have the highest prevalence at 8.6%, followed by non-Hispanic white adults at 7.7%, non-Hispanic Asian adults at 6.5%, and Hispanic adults at 4.8%. The difference between Black and white adults is not statistically significant, meaning both groups carry a roughly similar burden of the disease.

These numbers make clear that eczema is not a condition tied to any single race. It is widespread, and white populations are no exception.

What Eczema Looks Like on Light Skin

On white or light skin, eczema typically appears as red, weepy, crusty, flaky patches. These patches are often oval or circular and tend to show up where the skin flexes: inside the elbows, behind the knees, and along the front of the neck. The redness can range from a mild pink to an intense, angry red depending on how inflamed the skin is.

Common symptoms include dry and cracked skin, persistent itchiness, oozing and crusting during flare-ups, and skin that thickens over time from repeated scratching. Some people also notice darkening around the eyes. The inflammation can cover large areas of the body, like the chest and arms, or stay limited to a few small spots. In children, the pattern is fairly predictable, concentrated in those skin-fold areas. Adults often have a more scattered and unpredictable distribution, which can make it harder to identify.

Genetics and the Skin Barrier

One of the biggest risk factors for eczema in white populations is genetic. In 2006, researchers discovered that mutations in the filaggrin gene are a major driver of eczema risk. Filaggrin is a protein that helps form the outermost protective layer of the skin. When the gene that produces it is faulty, the skin barrier doesn’t hold together properly. Moisture escapes, irritants get in, and the immune system overreacts.

These filaggrin mutations are particularly common in people of European descent. They don’t guarantee you’ll develop eczema, but they significantly raise the odds. People who carry these mutations are also more likely to develop related allergic conditions like asthma, hay fever, and peanut allergy, a pattern sometimes called the “atopic march” where one allergic condition progresses to another over time.

Cold Weather and Environmental Triggers

White populations are concentrated in northern latitudes where cold, dry winters are the norm, and that climate is one of the most well-established environmental triggers for eczema. Cold air holds less moisture, and indoor heating further dries out the air inside homes. This combination strips moisture from the skin and weakens its protective barrier, making flare-ups more likely.

Research from Sweden has shown that colder temperatures, lower humidity, and stronger winds are directly associated with increased eczema-related healthcare visits. Studies across Europe and Asia consistently link winter months with higher eczema incidence. The International Eczema Council identifies cold, dry weather as a key environmental trigger, particularly for children.

Rapid shifts in skin temperature also play a role. Moving from frigid outdoor air into an overheated building can trigger intense itching and inflammation. Even being born in fall or winter slightly raises the risk of developing eczema, with one study finding a 15 to 16% increased odds compared to spring or summer births. For people living in northern climates, running a humidifier indoors during winter, using thicker moisturizers, and avoiding sudden temperature swings can help reduce flare frequency.

Eczema vs. Psoriasis on White Skin

On lighter skin tones, eczema and psoriasis can look strikingly similar. Both cause red, scaly, itchy patches, and early or mild psoriasis can easily be mistaken for eczema. The distinction matters because the conditions have different underlying causes and respond to different treatments.

A few visual clues help tell them apart. Psoriasis plaques tend to be well-defined with sharp borders and topped with thick, silvery scales. Eczema patches are usually less clearly outlined, more likely to ooze or crust, and often appear in skin folds rather than on outer surfaces like elbows and knees. Psoriasis also tends to involve more systemic inflammation. When blood work is done, psoriasis patients typically show higher markers of general inflammation, while eczema patients show elevated markers linked to allergic responses, like higher levels of the antibody IgE and increased eosinophils (a type of white blood cell involved in allergic reactions).

If you’re not sure which condition you’re dealing with, a dermatologist can usually tell from examining the skin. In ambiguous cases, a small skin biopsy or lab work can confirm the diagnosis.

How Treatment Works on Lighter Skin

The treatment approach for eczema is the same regardless of skin color: keep the skin moisturized, reduce inflammation during flares, and identify triggers. Most people manage mild to moderate eczema with daily moisturizers and prescription anti-inflammatory creams applied during flare-ups.

For moderate to severe cases that don’t respond well to creams alone, light therapy (phototherapy) is a common next step. Most clinical research on phototherapy has been conducted in people with lighter skin types (Fitzpatrick types II and III), so there is a solid evidence base for how well it works in this population. Narrowband UVB, the most widely used form, is effective for white patients at standard doses. Lighter skin requires lower starting doses than darker skin, and the treatment is gradually increased based on how the skin responds. Sessions are typically scheduled two to three times per week for several weeks.

Another form, UVA1 therapy, works equally well across all skin types without needing dose adjustments, and may be faster-acting for acute flare-ups. Both options are generally used alongside continued moisturizing and occasional use of topical treatments to maintain results between sessions.

Managing Eczema Long-Term

Eczema is a chronic condition for most people who have it. Flares come and go, often tied to seasonal changes, stress, contact with irritants like harsh soaps or wool clothing, or exposure to allergens like dust mites and pet dander. The goal of management isn’t to cure it but to extend the calm periods between flares and reduce their severity when they happen.

For white patients living in cold climates, winter preparation is especially important. Switching to heavier, fragrance-free moisturizers before the season turns, keeping indoor humidity between 40 and 60%, and wearing soft layers that don’t trap heat against the skin can all make a meaningful difference. Bathing in lukewarm water rather than hot, and applying moisturizer within a few minutes of getting out, helps lock in hydration before it evaporates. These daily habits, while simple, are often more effective at preventing flares than any medication used to treat them after they start.